Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Arrowhead Pharma (ARWR)

Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,308,530
  • Shares Outstanding, K 124,315
  • Annual Sales, $ 240,740 K
  • Annual Income, $ -205,280 K
  • EBIT $ -474 M
  • EBITDA $ -463 M
  • 60-Month Beta 0.93
  • Price/Sales 109.16
  • Price/Cash Flow N/A
  • Price/Book 7.84

Options Overview Details

View History
  • Implied Volatility 66.43% ( +4.70%)
  • Historical Volatility 55.98%
  • IV Percentile 68%
  • IV Rank 65.57%
  • IV High 86.91% on 02/29/24
  • IV Low 27.43% on 09/20/24
  • Put/Call Vol Ratio 3.76
  • Today's Volume 1,228
  • Volume Avg (30-Day) 361
  • Put/Call OI Ratio 0.47
  • Today's Open Interest 14,876
  • Open Int (30-Day) 13,318

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.63
  • Number of Estimates 9
  • High Estimate 0.54
  • Low Estimate -1.49
  • Prior Year -1.03
  • Growth Rate Est. (year over year) +38.83%

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.54 +0.16%
on 11/15/24
22.51 -17.50%
on 11/11/24
-1.31 (-6.59%)
since 10/15/24
3-Month
17.05 +8.91%
on 10/10/24
25.38 -26.83%
on 08/22/24
-4.09 (-18.05%)
since 08/15/24
52-Week
17.05 +8.91%
on 10/10/24
39.83 -53.38%
on 01/10/24
-8.44 (-31.25%)
since 11/15/23

Most Recent Stories

More News
Arrowhead Research: Fiscal Q3 Earnings Snapshot

Arrowhead Research: Fiscal Q3 Earnings Snapshot

ARWR : 18.57 (-13.26%)
Arrowhead Research: Fiscal Q2 Earnings Snapshot

Arrowhead Research: Fiscal Q2 Earnings Snapshot

ARWR : 18.57 (-13.26%)
Arrowhead Research: Fiscal Q1 Earnings Snapshot

Arrowhead Research: Fiscal Q1 Earnings Snapshot

ARWR : 18.57 (-13.26%)
Arrowhead Research: Fiscal Q3 Earnings Snapshot

Arrowhead Research: Fiscal Q3 Earnings Snapshot

ARWR : 18.57 (-13.26%)
Arrowhead Research: Fiscal Q2 Earnings Snapshot

Arrowhead Research: Fiscal Q2 Earnings Snapshot

ARWR : 18.57 (-13.26%)
Arrowhead Pharmaceuticals Reports Fiscal 2023 Second Quarter Results

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal second quarter ended March 31, 2023. The company is hosting a conference call today, May 2, 2023, at 4:30...

ARWR : 18.57 (-13.26%)
UPS, Packaging Corp. fall, Arrowhead, Tenet rise

Stocks that traded heavily or had substantial price changes Tuesday: UPS, Packaging Corp. fall, Arrowhead, Tenet rise

THC : 155.34 (-4.49%)
JBLU : 7.06 (-0.70%)
CNC : 57.46 (-2.08%)
ARWR : 18.57 (-13.26%)
UPS : 134.07 (+1.08%)
PEP : 158.62 (-3.95%)
Why Shares of Arrowhead Pharmaceuticals Are Up Tuesday

The clinical-stage biotech announced promising news regarding a potential therapy for inflammatory pulmonary diseases.

AMGN : 283.61 (-4.16%)
GSK : 33.35 (-1.91%)
TAK : 13.62 (+0.37%)
ARWR : 18.57 (-13.26%)
Arrowhead Pharmaceuticals’ Proprietary Pulmonary TRiM™ Platform Achieves High Levels of Target Gene Knockdown and Long Duration of Effect

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced interim results from an ongoing Phase 1/2 clinical study of ARO-RAGE, the company’s investigational RNA interference (RNAi) therapeutic designed...

ARWR : 18.57 (-13.26%)
Arrowhead Pharmaceuticals to Webcast Fiscal 2023 Second Quarter Results

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference call on May 2, 2023, at 4:30 p.m. ET to discuss its financial results for the fiscal 2023 second...

ARWR : 18.57 (-13.26%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company which develops novel drugs to treat intractable diseases primarily in the United States. The company's proprietary Dynamic Polyconjugate platform develops drugs based on the RNA interference mechanism which silences disease-causing genes....

See More

Key Turning Points

3rd Resistance Point 23.08
2nd Resistance Point 22.16
1st Resistance Point 20.37
Last Price 18.57
1st Support Level 17.66
2nd Support Level 16.74
3rd Support Level 14.95

See More

52-Week High 39.83
Fibonacci 61.8% 31.13
Fibonacci 50% 28.44
Fibonacci 38.2% 25.75
Last Price 18.57
52-Week Low 17.05

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar